Javascript must be enabled to continue!
Clinical characteristics of prostate cancer in Gunma Prefecture
View through CrossRef
Prostate cancer clinical data from patients registered at Gunma University Urologic Oncology Study Group were compared between pre‐PSA and PSA eras, dividing them between those patients diagnosed at clinical practice and those diagnosed on the Gunma mass‐screening programme.In the MS, the number of incidents of prostate cancer increased from 126 out of 16750 screened cases in the pre‐PSA era (0.75%) to 227 out of 19782 screened cases in the PSA era (1.15%). The average age was lower in the PSA era. As for clinical stage, stage B and C cases increased while stage D cases decreased.For the clinical practice cases at the Gunma University Urologic Oncology Study Group, the number of registered incidents of prostate cancer increased from 1164 in the pre‐PSA era to 2098 in the PSA era. The average age was similar between the pre‐PSA and PSA eras. The percentage of cases who were stage D declined from 46.1 during the pre‐PSA era to 37.7 in the PSA era.In the PSA era, earlier and more cases of prostate cancer are diagnosed both in clinical practice and in the mass screening program in Gunma Prefecture.
Title: Clinical characteristics of prostate cancer in Gunma Prefecture
Description:
Prostate cancer clinical data from patients registered at Gunma University Urologic Oncology Study Group were compared between pre‐PSA and PSA eras, dividing them between those patients diagnosed at clinical practice and those diagnosed on the Gunma mass‐screening programme.
In the MS, the number of incidents of prostate cancer increased from 126 out of 16750 screened cases in the pre‐PSA era (0.
75%) to 227 out of 19782 screened cases in the PSA era (1.
15%).
The average age was lower in the PSA era.
As for clinical stage, stage B and C cases increased while stage D cases decreased.
For the clinical practice cases at the Gunma University Urologic Oncology Study Group, the number of registered incidents of prostate cancer increased from 1164 in the pre‐PSA era to 2098 in the PSA era.
The average age was similar between the pre‐PSA and PSA eras.
The percentage of cases who were stage D declined from 46.
1 during the pre‐PSA era to 37.
7 in the PSA era.
In the PSA era, earlier and more cases of prostate cancer are diagnosed both in clinical practice and in the mass screening program in Gunma Prefecture.
Related Results
Abstract 4602: Clinicopathological and genetic features of prostate cancer in Algerian patients: First report
Abstract 4602: Clinicopathological and genetic features of prostate cancer in Algerian patients: First report
Abstract
Background: Prostate cancer is the second most frequent malignancy (after lung cancer) in men worldwide. It is the third most common cancer in men in Algeri...
Abstract 5758: Deletions of olfactomedin 4 gene is associated with progression of prostate cancer
Abstract 5758: Deletions of olfactomedin 4 gene is associated with progression of prostate cancer
Abstract
The human olfactomedin 4 gene (OLFM4) encodes an olfactomedin-related glycoprotein, which our group first cloned and characterized in myeloid cells and mapp...
Abstract 1568: The role of CCL2 CCL17 CCL22-CCR4 axis in prostate cancer metastasis
Abstract 1568: The role of CCL2 CCL17 CCL22-CCR4 axis in prostate cancer metastasis
Abstract
BACKGROUND: Multiple steps and factors are involved in prostate carcinogenesis and tumor progression. The early studies have found that tumor-associated mac...
Grade Group 1 Prostate Cancer Outcome by Biopsy Grade and Risk Group
Grade Group 1 Prostate Cancer Outcome by Biopsy Grade and Risk Group
ImportanceAdvocates for removing the cancer label from grade group 1 (GG1) prostate cancer detected on biopsy primarily base their argument on the observation that when only GG1 is...
Study on Early Prostate Cancer Antigen (EPCA) and existent risk factors of prostate cancer, Sudan: A case-control study
Study on Early Prostate Cancer Antigen (EPCA) and existent risk factors of prostate cancer, Sudan: A case-control study
Background: Early prostate cancer antigen (EPCA), a nuclear matrix protein, has recently been recommended as a hopeful biomarker for early prostate carcinogenesis. Objectives: To e...
Data from Dietary Fructose Promotes Prostate Cancer Growth
Data from Dietary Fructose Promotes Prostate Cancer Growth
<div>Abstract<p>Clinical localization of primary tumors and sites of metastasis by PET is based on the enhanced cellular uptake of 2-deoxy-2-[<sup>18</sup>F...
PROSTATE CANCER EPIDEMIOLOGY IN THE EAST KAZAKHSTAN REGION, 2010-2019
PROSTATE CANCER EPIDEMIOLOGY IN THE EAST KAZAKHSTAN REGION, 2010-2019
Relevance: From 2010 to 2019, prostate cancer morbidity increased, and prostate cancer mortality decreased in Kazakhstan. The peak incidence was observed in patients aged 70 years ...
PROSTATE CANCER EPIDEMIOLOGY IN THE EAST KAZAKHSTAN REGION, 2010-2019
PROSTATE CANCER EPIDEMIOLOGY IN THE EAST KAZAKHSTAN REGION, 2010-2019
Relevance: From 2010 to 2019, prostate cancer morbidity increased, and prostate cancer mortality decreased in Kazakhstan. The peak incidence was observed in patients aged 70 years ...

